Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Royal Caribbean Cruises Ltd (RCL) vs Teladoc Health Inc (TDOC) Price & Performance

Royal Caribbean Cruises LtdTrade
Teladoc Health IncTrade

Price performance (Past 24H)

Key statistics

Royal Caribbean Cruises Ltd vs Teladoc Health Inc — how do they compare? Royal Caribbean Cruises Ltd trades at $286.01 (market cap $76.75B), while Teladoc Health Inc trades at $8.91 (market cap $1.75B). The key difference: Royal Caribbean Cruises Ltd is far larger — about 43.9× Teladoc Health Inc's market cap, and Royal Caribbean Cruises Ltd pays a 1.75% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.

RCLTDOC
Market Cap
$76.75B$1.75B
Sector
Consumer CyclicalHealth
52-Week High
$365.84$9.72
52-Week Low
$246.71$4.47
Enterprise Value
$98.03B$2.04B
Dividend Yield
1.75%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Royal Caribbean Cruises Ltd

Royal Caribbean (RCL) trades at $287.90, near its 52-week high, with a modest 0.33% daily gain. The stock shows strong fundamental momentum, with revenue growing from $8.8B in 2022 to $17.9B in 2025 and net income surging to $4.3B. However, technical indicators signal a bearish trend, with moving averages and oscillators pointing to near-term pressure. Recent news highlights earnings anticipation and board appointments, while analyst consensus remains bullish with a $328 price target.

The outlook for RCL is positive based on robust earnings growth and expanding profit margins, but risks include high debt levels and potential economic sensitivity. Investor sentiment is mixed, with technical weakness offset by strong fundamentals. The stock presents a long-term opportunity if it can maintain operational execution amid competitive and macroeconomic challenges.

Teladoc Health Inc

TDOC trades at $9.71, up 2.97% with a bullish technical signal. The stock shows improving fundamentals with revenue stabilizing around $2.5B and narrowing losses. Recent earnings beat expectations in Q3 and Q4 2025 but missed in Q1 2026. Positive sentiment is driven by partnerships like Walmart Better Care and cost-cutting initiatives, though net margins remain negative.

The outlook suggests cautious optimism as operational improvements may drive recovery, but persistent losses and high debt pose risks. Analyst consensus is mixed with 36% buy ratings and a $9.50 price target, indicating limited upside. Investors should weigh cost-control progress against competitive pressures in telehealth.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Royal Caribbean Cruises Ltd

Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.

Read more on RCL

About Teladoc Health Inc

Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.

Read more on TDOC